Brief: Glenmark Pharma Says Glenmark Pharmaceuticals Inc Usa Launches Methylene Blue Injection Usp, 50 Mg/10 Ml Single-Dose Vial
17/06/2026 04:09
BRIEF-Glenmark Pharma Says Glenmark Pharmaceuticals Inc Usa Launches Methylene Blue Injection Usp, 50 Mg/10 Ml Single-Dose Vial June 17 (Reuters) - Glenmark Pharmaceuticals Ltd GLEN.NS:
GLENMARK PHARMA- GLENMARK PHARMACEUTICALS INC USA LAUNCHES METHYLENE BLUE INJECTION USP, 50 MG/10 ML SINGLE-DOSE VIAL
Source text: ID:nBSE5RLlqY
Further company coverage: GLEN.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Glenmark Pharmaceuticals
See all newsBrief: Glenmark Pharma Says Unit Launches Ryaltris Nasal Spray In Brazil For Allergic Rhinitis
Brief: Glenmark Pharma US Unit Launches Calcium Gluconate Injection USP In Multiple Vial Sizes
India's Glenmark Pharma gains most in three weeks on US approval for Flonase nasal spray
Brief: Glenmark Pharma Gets U.S. FDA Approval For Fluticasone Propionate Nasal Spray 0.05 Mg/Spray
India's Glenmark Pharmaceuticals falls as brokerage flags softer-than-expected quarter